Lataa...
Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease
Inflammatory bowel disease (IBD) includes two entities, Crohn’s disease and ulcerative colitis. Both are chronic conditions with frequent complications and surgical procedures and a great impact on patient’s quality of life. The thiopurine antimetabolites azathioprine and 6-mercaptopurine are widely...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The WJG Press and Baishideng
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2746337/ https://ncbi.nlm.nih.gov/pubmed/18810768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.5512 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|